Foghorn Therapeutics Inc.

NASDAQ:FHTX

8.85 (USD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -98.426-108.882-101.32-68.8-51.128-26.337
Depreciation & Amortization 3.4513.3213.2271.3270.6930.379
Deferred Income Tax 001.4120.0840.010.03
Stock Based Compensation 16.18614.3368.3842.9611.6940.732
Change In Working Capital -41.879281.54633.44128.7031.1972.424
Accounts Receivables 0300-300000
Inventory 00-3.171000
Accounts Payables 0.8461.6140.1350.4741.2111.276
Other Working Capital -42.725-20.068336.47728.229-0.0141.148
Other Non Cash Items 2.5623.2914.6064.4391.1990.124
Operating Cash Flow -118.106193.612-50.25-31.286-46.335-22.648
Investing Activities:
Investments In Property Plant And Equipment -1.224-1.21-3.313-16.183-0.968-1.541
Acquisitions Net 0243.112-39.4860.250.0040
Purchases Of Investments -73.901-409.345-99.984-92.98100
Sales Maturities Of Investments 219.575166.233139.47-0.2500
Other Investing Activites 0-243.11239.4860.250.0040
Investing Cash Flow 144.45-244.32236.173-108.914-0.964-1.541
Financing Activities:
Debt Repayment 00-21.2054.277.98411.14
Common Stock Issued 1.7781.76342.205122.12115.98540.63
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 1.7781.7631.41891.08215.98540.63
Financing Cash Flow 1.7781.76322.418217.47323.96951.77
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash 28.122-48.9478.34177.273-23.3327.581
Cash At End Of Period 82.04453.922102.86994.52817.25540.585